Empagliflozin confers reno‐protection in acute myocardial infarction and type 2 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empagliflozin confers reno‐protection in acute myocardial infarction and type 2 diabetes mellitus

Published:2021-07-07 Issue:5 Volume:8 Page:4161-4173
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Mozawa Kosuke¹,Kubota Yoshiaki¹^ORCID,Hoshika Yu¹,Tara Shuhei¹,Tokita Yukichi¹,Yodogawa Kenji¹,Iwasaki Yu‐ki¹,Yamamoto Takeshi¹,Takano Hitoshi¹,Tsukada Yayoi¹,Asai Kuniya¹,Miyamoto Masaaki¹,Miyauchi Yasushi²,Kodani Eitaro³,Maruyama Mitsunori⁴,Tanabe Jun⁵,Shimizu Wataru¹

Affiliation:

1. Department of Cardiovascular Medicine Nippon Medical School 1‐1‐5, Sendagi, Bunkyo‐ku Tokyo 113‐0022 Japan

2. Department of Cardiovascular Medicine Nippon Medical School Chiba Hokuso Hospital Chiba Japan

3. Department of Cardiovascular Medicine Nippon Medical School Tama Nagayama Hospital Tokyo Japan

4. Department of Cardiovascular Medicine Nippon Medical School Musashi Kosugi Hospital Tokyo Japan

5. Department of Cardiovascular Medicine Shizuoka Medical Center Shizuoka Japan

Funder

Eli Lilly and Company

Boehringer Ingelheim

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13509

Reference28 articles.

1. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

2. Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes

3. Clinical features and therapeutic perspectives on hypertension in diabetics

4. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

5. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of empagliflozin on serum uric acid level of patients with type 2 diabetes mellitus: a systematic review and meta‐analysis;Diabetology & Metabolic Syndrome;2023-10-16

2. Influence and mechanism of sodium-glucose cotransporter-2 inhibitors on the cardiac function: study protocol for a prospective cohort study;Frontiers in Endocrinology;2023-07-19

3. SGLT2 inhibitors for prevention of primary and secondary cardiovascular outcomes: A meta-analysis of randomized controlled trials;Heart & Lung;2023-05

4. Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction;Cardiovascular Diabetology;2023-02-06

5. Management of Type 2 Diabetes in Acute Coronary Syndromes: Current State and Future Perspectives;Current Pharmaceutical Design;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3